Company Spotlight / Fujifilm MEA: From Film to the Future
When the photographic film industry faced a crisis in the early 2000s, market leader Kodak began to struggle and…
MIDDLE EAST & AFRICA
MEA / Saudi Arabia’s Bold Ambition to Become a Regional Pharma Hub
Saudi Arabia is aiming to become a more attractive investment destination for multinational pharma companies…
MEA / The UAE’s Fight Against Genetic Diseases
With a relatively high number of genetic disorders, the Arab population of the United Arab Emirates (UAE) is…
Digitalization / Dubai Aims to Go Paperless by 2021
Dubai’s government has announced its ambition to go completely paper-free by the end of the year 2021. Its…
Pharma Faces / Karim Smaira & Kamel Ghammachi of Genpharm
With a combined experience of over five decades in the pharmaceutical industry including senior executive roles at…
Early Access / The UAE as an Initial Product Launch Platform
The UAE’s distinctive willingness to embrace innovation and the ‘can-do’ spirit of authorities marks the…
Top 10 Pharma Companies in Morocco Ranking
The top 10 pharma companies in Morocco ranked by sales value for Q4 2018. French giant Sanofi takes top spot,…
Pharma Faces / Paolo Carli, Merck MEAR
Paolo Carli, head of Middle East, Africa, Turkey, Russia and CIS (MEAR) for Merck has continually taken on greater…
Morocco Local Production Snapshot
A new IQVIA study sponsored by LEMM, the Moroccan association of multinationals looked at 3,437 references sold on…
In Conversation
Guillaume Freneuil – Vice President Intercontinental Operations, Consumer Healthcare Division, Ipsen
Ipsen’s Guillaume Freneuil gives his take on the importance of the Algerian market to the global group. If we are investing right now in Algeria it is because we envisage further growth here to be able to serve patient needs 33 percent of Sales within Ipsen are now in developing markets. Do you see Algeria as being one of…
Latest Reports
Focus on Egypt
Striking the Access/Innovation Balance in Egyptian…
As Egypt rolls out Universal Health Insurance with the aim of achieving full…
GE Healthcare Egypt: Reimagining Care Provision
Amro Kandil, managing director Northeast Africa for GE Healthcare, outlines how…
Read more from Egypt >>
Focus on Algeria
Countering Algeria’s Diabetes Epidemic, With Pharmacists?
Yacine Sellam examines how pharmacists in Algeria can follow the lead of their…
European Solutions to Algeria’s Medicine Supply Shortages
Yacine Sellam, president of the Algerian Society for Regulatory Affairs &…
Read more from Algeria >>
Focus on Turkey
Acıbadem’s Grand Ambitions
There is perhaps no Turkish company in the healthcare sector that is more…
CEO Profile: Ferhat Farsi, CinnaGen İlaç
Dr Ferhat Farsi, CEO and founding partner of CinnaGen İlaç, shares his…
Read more from Turkey >>
Focus on Morocco
Morocco: Becoming a Pharma Manufacturing Hub for Africa
Multinational pharmaceutical companies are increasingly seeing Morocco as a top…
New IQVIA Study Sparks Controversy in Moroccan Pharma
Ensuring the country’s “sanitary sovereignty” has long been a key policy…
Read more from Morocco >>
Cancer Immunotherapy in Algeria: Between Therapeutic Progress and Budget…
Yacine Sellam, president of the Algerian Society for Regulatory Affairs & Pharmacoeconomics, outlines the…
Drug Shortage / European Solutions to Algeria’s Medicine Supply Shortages
Yacine Sellam, president of the Algerian Society for Regulatory Affairs & Pharmacoeconomics, looks at how…
MEA / Gulf Healthcare Costs to Rise Drastically in 2020
Growing incidence of lifestyle-related diseases, coupled with high drug prices, are driving up healthcare costs at…
Tunisia: Diabetes on the Rise
Diabetes is an important problem in Tunisia, with prevalence is expected to increase over the coming years.…
Egypt: Making Moves Towards Universal Healthcare
Last week saw the first meeting of the board of Egypt’s new Universal Healthcare Authority (UHA) managed by…
IP / Striking the Access/Innovation Balance in Egyptian Healthcare
As Egypt rolls out Universal Health Insurance with the aim of achieving full coverage between 2030 and 2035, the…